About Transcriptional regulator ERG
Transcriptional regulator ERG (ERG) is a protein
from Homo sapiens identified by UniProt accession
P11308, 479 residues long.
MolForge cross-references it against 0 known binders and
393 disease associations.
Target properties
| Protein name | Transcriptional regulator ERG |
| UniProt accession | P11308 |
| Gene | ERG |
| Organism | Homo sapiens |
| Length | 479 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (393)
Diseases linked to this target (Open Targets).
- mean corpuscular volume · score 0.51
- erythrocyte count · score 0.50
- basophil count · score 0.50
- refractive error measurement · score 0.50
- monocyte count · score 0.50
- platelet count · score 0.50
- leukocyte count · score 0.49
- eosinophil count · score 0.49
- mean corpuscular hemoglobin · score 0.48
- neutrophil count · score 0.48
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P11308-F1 | alphafold | PREDICTED | 59.36 | — |
Amino-acid sequence (479 residues)
MASTIKEALS VVSEDQSLFE CAYGTPHLAK TEMTASSSSD YGQTSKMSPR VPQQDWLSQP PARVTIKMEC NPSQVNGSRN SPDECSVAKG GKMVGSPDTV GMNYGSYMEE KHMPPPNMTT NERRVIVPAD PTLWSTDHVR QWLEWAVKEY GLPDVNILLF QNIDGKELCK MTKDDFQRLT PSYNADILLS HLHYLRETPL PHLTSDDVDK ALQNSPRLMH ARNTGGAAFI FPNTSVYPEA TQRITTRPDL PYEPPRRSAW TGHGHPTPQS KAAQPSPSTV PKTEDQRPQL DPYQILGPTS SRLANPGSGQ IQLWQFLLEL LSDSSNSSCI TWEGTNGEFK MTDPDEVARR WGERKSKPNM NYDKLSRALR YYYDKNIMTK VHGKRYAYKF DFHGIAQALQ PHPPESSLYK YPSDLPYMGS YHAHPQKMNF VAPHPPALPV TSSSFFAAPN PYWNSPTGGI YPNTRLPTSH MPSHLGTYY
Explore Transcriptional regulator ERG with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets